These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 34007998)

  • 1. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report.
    Bianchi FP; Germinario CA; Migliore G; Vimercati L; Martinelli A; Lobifaro A; Tafuri S; Stefanizzi P;
    J Infect Dis; 2021 Aug; 224(3):431-434. PubMed ID: 34007998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection control, occupational and public health measures including mRNA-based vaccination against SARS-CoV-2 infections to protect healthcare workers from variants of concern: A 14-month observational study using surveillance data.
    Yassi A; Grant JM; Lockhart K; Barker S; Sprague S; Okpani AI; Wong T; Daly P; Henderson W; Lubin S; Kim Sing C
    PLoS One; 2021; 16(7):e0254920. PubMed ID: 34270608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study.
    Bianchi FP; Tafuri S; Migliore G; Vimercati L; Martinelli A; Lobifaro A; Diella G; Stefanizzi P;
    Vaccines (Basel); 2021 Oct; 9(10):. PubMed ID: 34696252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    Chung H; He S; Nasreen S; Sundaram ME; Buchan SA; Wilson SE; Chen B; Calzavara A; Fell DB; Austin PC; Wilson K; Schwartz KL; Brown KA; Gubbay JB; Basta NE; Mahmud SM; Righolt CH; Svenson LW; MacDonald SE; Janjua NZ; Tadrous M; Kwong JC;
    BMJ; 2021 Aug; 374():n1943. PubMed ID: 34417165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.
    Paris C; Perrin S; Hamonic S; Bourget B; Roué C; Brassard O; Tadié E; Gicquel V; Bénézit F; Thibault V; Garlantézec R; Tattevin P
    Clin Microbiol Infect; 2021 Nov; 27(11):1699.e5-1699.e8. PubMed ID: 34265462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of BNT162b2 vaccination with SARS-CoV-2 infection and hospital admission and death with covid-19 in nursing homes and healthcare workers in Catalonia: prospective cohort study.
    Cabezas C; Coma E; Mora-Fernandez N; Li X; Martinez-Marcos M; Fina F; Fabregas M; Hermosilla E; Jover A; Contel JC; Lejardi Y; Enfedaque B; Argimon JM; Medina-Peralta M; Prieto-Alhambra D
    BMJ; 2021 Aug; 374():n1868. PubMed ID: 34407952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
    Chodick G; Tene L; Patalon T; Gazit S; Ben Tov A; Cohen D; Muhsen K
    JAMA Netw Open; 2021 Jun; 4(6):e2115985. PubMed ID: 34097044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
    Thompson MG; Burgess JL; Naleway AL; Tyner H; Yoon SK; Meece J; Olsho LEW; Caban-Martinez AJ; Fowlkes AL; Lutrick K; Groom HC; Dunnigan K; Odean MJ; Hegmann K; Stefanski E; Edwards LJ; Schaefer-Solle N; Grant L; Ellingson K; Kuntz JL; Zunie T; Thiese MS; Ivacic L; Wesley MG; Mayo Lamberte J; Sun X; Smith ME; Phillips AL; Groover KD; Yoo YM; Gerald J; Brown RT; Herring MK; Joseph G; Beitel S; Morrill TC; Mak J; Rivers P; Poe BP; Lynch B; Zhou Y; Zhang J; Kelleher A; Li Y; Dickerson M; Hanson E; Guenther K; Tong S; Bateman A; Reisdorf E; Barnes J; Azziz-Baumgartner E; Hunt DR; Arvay ML; Kutty P; Fry AM; Gaglani M
    N Engl J Med; 2021 Jul; 385(4):320-329. PubMed ID: 34192428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BNT162b2 vaccine uptake and effectiveness in UK healthcare workers - a single centre cohort study.
    Azamgarhi T; Hodgkinson M; Shah A; Skinner JA; Hauptmannova I; Briggs TWR; Warren S
    Nat Commun; 2021 Jun; 12(1):3698. PubMed ID: 34140469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the BNT162b2 COVID-19 vaccine effective in elderly populations? Results from population data from Bavaria, Germany.
    Gomes D; Beyerlein A; Katz K; Hoelscher G; Nennstiel U; Liebl B; Überla K; von Kries R
    PLoS One; 2021; 16(11):e0259370. PubMed ID: 34739520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India.
    Malhotra S; Mani K; Lodha R; Bakhshi S; Mathur VP; Gupta P; Kedia S; Sankar J; Kumar P; Kumar A; Ahuja V; Sinha S; Guleria R; ; Dua A; Ahmad S; Sathiyamoorthy R; Sharma A; Sakya T; Gaur V; Chaudhary S; Sharma S; Madan D; Gupta A; Virmani S; Gupta A; Yadav N; Sachdeva S; Sharma S; Singh S; Pandey A; Singh M; Jhurani D; Sarkar S; Lokade AK; Mohammad A; Pandit S; Dubey R; Singh AK; Gohar N; Soni D; Bhattacharyya A; Rai S; Tummala S; Gupta I; Shukla S
    JAMA Netw Open; 2022 Jan; 5(1):e2142210. PubMed ID: 34994793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data.
    Glatman-Freedman A; Bromberg M; Dichtiar R; Hershkovitz Y; Keinan-Boker L
    EBioMedicine; 2021 Oct; 72():103574. PubMed ID: 34537449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea.
    Bae S; Lee YW; Lim SY; Lee JH; Lim JS; Lee S; Park S; Kim SK; Lim YJ; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH
    J Korean Med Sci; 2021 May; 36(17):e115. PubMed ID: 33942579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Waning of BNT162b2 Vaccine Effectiveness for SARS-CoV-2 Infection Prevention over Time: A Test-Negative Study in Health Care Professionals of a Health Department from January 2021 to December 2021.
    Jiménez-Sepúlveda N; Chico-Sánchez P; Castro-García JM; Escribano-Cañadas I; Merino-Lucas E; Ronda-Pérez E; Sánchez-Payá J; Gras-Valentí P; On Behalf Of The Covid-Preventive Medicine Group
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 among healthcare workers.
    Sansone E; Sala E; Tiraboschi M; Albini E; Lombardo M; Indelicato A; Rosati C; Boniotti MB; Castelli F; De Palma G
    Med Lav; 2021 Jun; 112(3):250-255. PubMed ID: 34142670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faster decay of neutralizing antibodies in never infected than previously infected healthcare workers three months after the second BNT162b2 mRNA COVID-19 vaccine dose.
    Vicenti I; Basso M; Gatti F; Scaggiante R; Boccuto A; Zago D; Modolo E; Dragoni F; Parisi SG; Zazzi M
    Int J Infect Dis; 2021 Nov; 112():40-44. PubMed ID: 34481967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea.
    Lee YW; Lim SY; Lee JH; Lim JS; Kim M; Kwon S; Joo J; Kwak SH; Kim EO; Jung J; Kwon HS; Kim TB; Kim SH; Bae S
    J Korean Med Sci; 2021 May; 36(21):e153. PubMed ID: 34060261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of the first dose of BNT162b2 vaccine to preventing covid-19 in healthcare personnel.].
    Gras-Valentí P; Chico-Sánchez P; Algado-Sellés N; Jiménez-Sepúlveda NJ; Gómez-Sotero IL; Fuster-Pérez M; Cartagena-Llopis L; Sánchez-Valero M; Cerezo-Milán P; Martínez-Tornero I; Tremiño-Sánchez L; Nadal-Morante V; Monerris-Palmer M; Esclapez-Martínez A; MorenodeArcos-Fuentes E; Escalada-Martín I; Escribano-Cañadas I; Merino-Lucas E; Rodríguez-Díaz JC; Sánchez-Payá J
    Rev Esp Salud Publica; 2021 Apr; 95():. PubMed ID: 33913444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic SARS-CoV-2 infections after full schedule BNT162b2 vaccination in seropositive healthcare workers: a case series from a single institution.
    Baj A; Novazzi F; Genoni A; Ferrante FD; Taborelli S; Pini B; Partenope M; Valli M; Gasperina DD; Capuano R; Prestia M; Spezia PG; Azzi L; Focosi D; Maggi F
    Emerg Microbes Infect; 2021 Dec; 10(1):1254-1256. PubMed ID: 34110974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.
    Dagan N; Barda N; Biron-Shental T; Makov-Assif M; Key C; Kohane IS; Hernán MA; Lipsitch M; Hernandez-Diaz S; Reis BY; Balicer RD
    Nat Med; 2021 Oct; 27(10):1693-1695. PubMed ID: 34493859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.